Real-world Effectiveness of Original BNT162b2 Mrna COVID-19 Against Symptomatic Omicron Infection among Children 5-11 Years of Age in Brazil: a Prospective Test-Negative Design Study Cristina de Oliveira Rodrigues , Julia Spinardi , Regis Goulart Rosa , Maicon Falavigna , Emanuel Maltempi de Souza , Joselia Larger Manfio , Ana Paula de Souza , Cintia Laura Pereira de Araujo , Mirian Cohen , Gynara Rezende Gonzalez do Valle Barbosa , Fernanda Kelly Romeiro Silva , Daniel Sganzerla , Mariana Motta Dias da Silva , Diogo Ferreira , Nicolas Taciano Kunkel , Nathan Iori Camargo , Jean Carlos Sarturi , Marcia Cristina Guilhem , Jaqueline Carvalho de Oliveira , Caroline Cardoso Lopes , Fernanda Widmar , Leticia Killes Barufi , Gabrielle Nunes da Silva , Daniela Fiori Gradia , Ana Paula Carneiro Brandalize , Carla Adriane Royer , Rafael Messias Luiz , Valter Antonio Baura , Hellen Abreu , Carolina Gracia Poitevin , Gabriela Almeida Kucharski , Fernando Pedrotti , Srinivas Rao Valluri , Amit Srivastava , Viviane Wal Juliao , Olga Chameh Melone , Kristen E. Allen , Moe H. Kyaw , Graciela del Carmen Morales Castillo , John Mclaughlin Immunology letters（2024）
Key words
COVID-19 Vaccines, BNT162b2 vaccine, SARS-CoV-2 variants, Treatment outcome, Child
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
